Across CVD contexts, immune cell AR signaling can amplify injury or constrain inflammation, thereby influencing endothelial dysfunction, vascular remodeling, fibrosis, microvascular impairment, and long-term organ function. The gene discussed is AR; the disease is endothelial dysfunction.